- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Hikal Limited — Updates, 13-11-2025: Press Release
13-11-2025 | 04:37 pm
13-11-2025 | 04:37 pm
Hikal's Q2 revenue fell to ₹319 Cr, posting a ₹35 Cr loss due to pharma sales deferrals from regulatory issues and muted Crop Protection. Management anticipates a strong H2 recovery, backed by new products and improved demand. Diversification into HPAPI and personal care continues.
No comments yet. Be the first to comment!